Global Patterns of Cancer Incidence and Mortality Rates and Trends
Tóm tắt
While incidence and mortality rates for most cancers (including lung, colorectum, female breast, and prostate) are decreasing in the United States and many other western countries, they are increasing in several less developed and economically transitioning countries because of adoption of unhealthy western lifestyles such as smoking and physical inactivity and consumption of calorie-dense food. Indeed, the rates for lung and colon cancers in a few of these countries have already surpassed those in the United States and other western countries. Most developing countries also continue to be disproportionately affected by cancers related to infectious agents, such as cervix, liver, and stomach cancers. The proportion of new cancer cases diagnosed in less developed countries is projected to increase from about 56% of the world total in 2008 to more than 60% in 2030 because of the increasing trends in cancer rates and expected increases in life expectancy and growth of the population. In this review, we describe these changing global incidence and mortality patterns for select common cancers and the opportunities for cancer prevention in developing countries. Cancer Epidemiol Biomarkers Prev; 19(8); 1893–907. ©2010 AACR.
Từ khóa
Tài liệu tham khảo
Kolonel, 2006, Migrant studies, Cancer epidemiology and prevention, 3rd ed, 189, 10.1093/acprof:oso/9780195149616.003.0011
Buell, 1965, Cancer mortality among Japanese Issei and Nisei of California, Cancer, 18, 656, 10.1002/1097-0142(196505)18:5<656::AID-CNCR2820180515>3.0.CO;2-3
Shafey, 2003, Tobacco control country profiles, 2nd ed.
McAllister, 2009, Ten putative contributors to the obesity epidemic, Crit Rev Food Sci Nutr, 49, 868, 10.1080/10408390903372599
Popkin, 2006, Global nutrition dynamics: the world is shifting rapidly toward a diet linked with noncommunicable diseases, Am J Clin Nutr, 84, 289, 10.1093/ajcn/84.2.289
Kanavos, 2006, The rising burden of cancer in the developing world, Ann Oncol, 17, viii15, 10.1093/annonc/mdl983
Center, 2009, Worldwide variations in colorectal cancer, CA Cancer J Clin, 59, 366, 10.3322/caac.20038
American Cancer Society, 2007, Global cancer facts & figures 2007
Thun, 2010, The global burden of cancer: priorities for prevention, Carcinogenesis, 31, 100, 10.1093/carcin/bgp263
Ferlay, 2010, GLOBOCAN 2008, Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]
World Health Organization, 2007, Ten statistical highlights in global public health, World health statistics 2007
International Agency for Cancer Research (IARC). CANCERMondial; available from: http://www-dep.iarc.fr/. Accessed on March 22, 2009.
Anderson, 1998, Age standardization of death rates: implementation of the year 2000 standard, Natl Vital Stat Rep, 47, 1
Jemal, 2005, Cancer statistics, Cancer principles and practice of oncology, 7th ed., 226
Youlden, 2008, The international epidemiology of lung cancer: geographical distribution and secular trends, J Thorac Oncol, 3, 819, 10.1097/JTO.0b013e31818020eb
Bray, 2010, Lung cancer mortality trends in 36 European countries: secular trends and birth cohort patterns by sex and region 1970-2007, Int J Cancer, 126, 1454, 10.1002/ijc.24855
Ezzati, 2005, Role of smoking in global and regional cancer epidemiology: current patterns and data needs, Int J Cancer, 116, 963, 10.1002/ijc.21100
Ezzati, 2003, Estimates of global mortality attributable to smoking in 2000, Lancet, 362, 847, 10.1016/S0140-6736(03)14338-3
Peto, 2006, Mortality from smoking in developed countries 1950-2000, 2nd ed
Jemal, 2008, Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control, J Natl Cancer Inst, 100, 1672, 10.1093/jnci/djn389
Lam, 2004, Lung cancer epidemiology and risk factors in Asia and Africa, Int J Tuberc Lung Dis, 8, 1045
Glynn, 2010, The globalization of tobacco use: 21 challenges for the 21st century, CA Cancer J Clin, 60, 50, 10.3322/caac.20052
Yach, 2005, Improving diet and physical activity: 12 lessons from controlling tobacco smoking, BMJ, 330, 898, 10.1136/bmj.330.7496.898
Hafez, 2005, How Philip Morris built Marlboro into a global brand for young adults: implications for international tobacco control, Tob Control, 14, 262, 10.1136/tc.2005.011189
Warner, 2006, The global tobacco disease pandemic: nature, causes, and cures, Glob Public Health, 1, 65, 10.1080/17441690500430771
World Health Organization. WHO Framework Convention on Tobacco Control; [cited 2010 March 9]. Available from: http://whqlibdoc.who.int/publications/2003/9241591013.pdf.
Centers for Disease Control and Prevention, 2007, Best practices for comprehensive tobacco control programs—2007
FCTC Convention Secretariat. 2009 Summary report on global progress in implementation of the WHO Framework Convention on Tobacco Control
2009 [cited 2010 March 9]. Available from: http://www.who.int/fctc/FCTC-2009-1-en.pdf.
Spitz, 2006, Cancer of the lung
Mackay, 2006, The tobacco atlas, 2nd ed
Boffetta, 2003, Contribution of environmental factors to cancer risk, Br Med Bull, 68, 71, 10.1093/bmp/ldg023
Thun, 2008, Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies, PLoS MEd, 5, e185, 10.1371/journal.pmed.0050185
Center, 2009, International trends in colorectal cancer incidence rates, Cancer Epidemiol Biomarkers Prev, 18, 1688, 10.1158/1055-9965.EPI-09-0090
Garcia-Alvarez, 2007, Obesity and overweight trends in Catalonia, Spain (1992-2003): gender and socio-economic determinants, Public Health Nutr, 10, 1368, 10.1017/S1368980007000973
Martin, 2008, Trends in childhood and adolescent obesity prevalence in Oviedo (Asturias, Spain) 1992-2006, Acta Paediatr, 97, 955, 10.1111/j.1651-2227.2008.00828.x
de Kok, 2008, Gender differences in the trend of colorectal cancer incidence in Singapore, 1968-2002, Int J Colorectal Dis, 23, 461, 10.1007/s00384-007-0421-9
Berghofer, 2008, Obesity prevalence from a European perspective: a systematic review, BMC Public Health, 8, 200, 10.1186/1471-2458-8-200
Edwards, 2010, Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates, Cancer, 116, 544, 10.1002/cncr.24760
Chu, 1994, Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990, J Natl Cancer Inst, 86, 997, 10.1093/jnci/86.13.997
Mitry, 2002, Benefit of operative mortality reduction on colorectal cancer survival, Br J Surg, 89, 1557, 10.1046/j.1365-2168.2002.02276.x
Sant, 2001, Cancer survival increases in Europe, but international differences remain wide, Eur J Cancer, 2001, 1659, 10.1016/S0959-8049(01)00206-4
Sankaranarayanan, 1999, Cancer survival in developing countries
Sankaranarayanan, 2009, Cancer survival in Africa, Asia, and Central America: a population-based study, Lancet Oncol, 11, 110
Coleman, 2008, Cancer survival in five continents: a worldwide population-based study (CONCORD), Lancet Oncol, 9, 730, 10.1016/S1470-2045(08)70179-7
Sant, 2009, EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary, Eur J Cancer, 45, 931, 10.1016/j.ejca.2008.11.018
Mandel, 1993, Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study, N Engl J Med, 328, 1365, 10.1056/NEJM199305133281901
Zauber, 2008, Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force, Ann Intern Med, 149, 659, 10.7326/0003-4819-149-9-200811040-00244
Muller, 1995, Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans, Ann Intern Med, 123, 904, 10.7326/0003-4819-123-12-199512150-00002
Benson, 2008, Colorectal cancer screening: a comparison of 35 initiatives in 17 countries, Int J Cancer, 122, 1357, 10.1002/ijc.23273
Parkin, 2006, Use of statistics to assess the global burden of breast cancer, Breast J, 12, S70, 10.1111/j.1075-122X.2006.00205.x
Zahl, 2008, The natural history of invasive breast cancers detected by screening mammography, Arch Intern Med, 168, 2311, 10.1001/archinte.168.21.2311
Roa, 1996, Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2, Nat Genet, 14, 185, 10.1038/ng1096-185
Antoniou, 2003, Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies, Am J Hum Genet, 72, 1117, 10.1086/375033
American Cancer Society, 2009, Breast cancer facts & figures 2009-2010
Ravdin, 2007, The decrease in breast-cancer incidence in 2003 in the United States, N Engl J Med, 356, 1670, 10.1056/NEJMsr070105
Cronin, 2009, Sustained lower rates of breast cancer in the United States, Breast Cancer Res Treat, 117, 223, 10.1007/s10549-008-0226-8
Glass, 2007, Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status, J Natl Cancer Inst, 99, 1152, 10.1093/jnci/djm059
Breen, 2007, Reported drop in mammography: is this cause for concern?, Cancer, 109, 2405, 10.1002/cncr.22723
Jemal, 2007, Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women, Breast Cancer Res, 9, R28, 10.1186/bcr1672
Pelucchi, 2010, The rise and fall in menopausal hormone therapy and breast cancer incidence, Breast, 19, 198, 10.1016/j.breast.2010.01.021
Parkin, 2009, Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy?, Eur J Cancer, 45, 1649, 10.1016/j.ejca.2009.01.016
Seradour, 2009, Changes by age in breast cancer incidence, mammography screening and hormone therapy use in France from 2000 to 2006, Bull Cancer, 96, E1
Canfell, 2008, Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia, Med J Aust, 188, 641, 10.5694/j.1326-5377.2008.tb01821.x
Althuis, 2005, Global trends in breast cancer incidence and mortality 1973-1997, Int J Epidemiol, 34, 405, 10.1093/ije/dyh414
Berry, 2005, Effect of screening and adjuvant therapy on mortality from breast cancer, N Engl J Med, 353, 1784, 10.1056/NEJMoa050518
Levi, 2005, Monitoring the decrease in breast cancer mortality in Europe, Eur J Cancer Prev, 14, 497, 10.1097/00008469-200512000-00002
Sant, 2006, Time trends of breast cancer survival in Europe in relation to incidence and mortality, Int J Cancer, 119, 2417, 10.1002/ijc.22160
Freitas-Junior, 2008, Variations in breast cancer incidence per decade of life (Goiania, GO, Brazil): 16-year analysis, Cancer Causes Control, 19, 681, 10.1007/s10552-008-9131-z
Takiar, 2008, Time trend in breast and cervix cancer of women in India (1990-2003), Asian Pac J Cancer Prev, 9, 777
Bosetti, 2005, Trends in cancer mortality in the Americas, 1970-2000, Ann Oncol, 16, 489, 10.1093/annonc/mdi086
Parkin, 2010, Changing cancer incidence in Kampala, Uganda, 1991-2006, Int J Cancer, 126, 1187, 10.1002/ijc.24838
Prentice, 2006, The emerging epidemic of obesity in developing countries, Int J Epidemiol, 35, 93, 10.1093/ije/dyi272
Colditz, 2006, Epidemiology—identifying the causes and preventability of cancer?, Nat Rev, 6, 75, 10.1038/nrc1784
Prentice, 2009, Obesity in emerging nations: evolutionary origins and the impact of a rapid nutrition transition, Nestle Nutr Workshop Ser Pediatr Program, 63, 47, 10.1159/000209972
Anderson, 2006, Breast cancer in limited-resource countries: health care systems and public policy, Breast J, 12, S54, 10.1111/j.1075-122X.2006.00203.x
Anderson, 2008, Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007, Cancer, 113, 2221, 10.1002/cncr.23844
CancerCareAfrica. Available from: http://cancercareafrica.org/mother.html; accessed on March 8, 2010.
Hsing, 2000, International trends and patterns of prostate cancer incidence and mortality, Int J Cancer, 85, 60, 10.1002/(SICI)1097-0215(20000101)85:1<60::AID-IJC11>3.0.CO;2-B
Baade, 2009, International epidemiology of prostate cancer: geographical distribution and secular trends, Mol Nutr Food Res, 53, 171, 10.1002/mnfr.200700511
Quinn, 2002, Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons, BJU Int, 90, 162, 10.1046/j.1464-410X.2002.2822.x
Draisma, 2009, Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context, J Natl Cancer Inst, 101, 374, 10.1093/jnci/djp001
Etzioni, 2002, Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends, J Natl Cancer Inst, 94, 981, 10.1093/jnci/94.13.981
Armstrong, 1975, Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices, Int J Cancer, 15, 617, 10.1002/ijc.2910150411
Rose, 1986, International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption, Cancer, 58, 2363, 10.1002/1097-0142(19861201)58:11<2363::AID-CNCR2820581102>3.0.CO;2-#
Hayes, 1999, Dietary factors and risks for prostate cancer among blacks and whites in the United States, Cancer Epidemiol Biomarkers Prev, 8, 25
Whittemore, 1995, Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada, J Natl Cancer Inst, 87, 652, 10.1093/jnci/87.9.652
Glover, 1998, The epidemiology of prostate cancer in Jamaica, J Urol, 159, 1984, 10.1016/S0022-5347(01)63220-8
Bunker, 2002, High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey, Cancer Epidemiol Biomarkers Prev, 11, 726
Bock, 2009, Results from a prostate cancer admixture mapping study in African-American men, Hum Genet, 126, 637, 10.1007/s00439-009-0712-z
Miller, 2003, Germ-line mutations of the macrophage scavenger receptor 1 gene: association with prostate cancer risk in African-American men, Cancer Res, 63, 3486
Collin, 2008, Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study, Lancet Oncol, 9, 445, 10.1016/S1470-2045(08)70104-9
Etzioni, 2008, Quantifying the role of PSA screening in the US prostate cancer mortality decline, Cancer Causes Control, 19, 175, 10.1007/s10552-007-9083-8
Andriole, 2009, Mortality results from a randomized prostate-cancer screening trial, N Engl J Med, 360, 1310, 10.1056/NEJMoa0810696
Schroder, 2009, Screening and prostate-cancer mortality in a randomized European study, N Engl J Med, 360, 1320, 10.1056/NEJMoa0810084
Parkin, 2006, The global health burden of infection-associated cancers in the year 2002, Int J Cancer, 118, 3030, 10.1002/ijc.21731
International Agency for Research on Cancer (IARC). Tobacco smoke and involuntary smoking. 2002 [cited October 6]
Vol. 83 (2002). Available from: http://monographs.iarc.fr/ENG/Monographs/vol83/volume83.pdf.
Joossens, 1996, Dietary salt, nitrate and stomach cancer mortality in 24 countries, Int J Epidemiol, 25, 494, 10.1093/ije/25.3.494
Bertuccio, 2009, Recent patterns in gastric cancer: a global overview, Int J Cancer, 125, 666, 10.1002/ijc.24290
Botterweck, 2000, Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries, Int J Epidemiol, 29, 645, 10.1093/ije/29.4.645
Devesa, 1998, Changing patterns in the incidence of esophageal and gastric carcinoma in the United States, Cancer, 83, 2049, 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2
El-Serag, 2007, Time trends of gastroesophageal reflux disease: a systematic review, Clin Gastroenterol Hepatol, 5, 17, 10.1016/j.cgh.2006.09.016
Blot, 1991, Rising incidence of adenocarcinoma of the esophagus and gastric cardia, JAMA, 265, 1287, 10.1001/jama.1991.03460100089030
Shibata, 2006, Stomach cancer, Cancer epidemiology and prevention, 3rd ed., 707, 10.1093/acprof:oso/9780195149616.003.0037
Hamashima, 2008, The Japanese guidelines for gastric cancer screening, Jpn J Clin Oncol, 38, 259, 10.1093/jjco/hyn017
Yoo, 2008, Cancer control activities in the Republic of Korea, Jpn J Clin Oncol, 38, 327, 10.1093/jjco/hyn026
Fock, 2008, Asia-Pacific consensus guidelines on gastric cancer prevention, J Gastroenterol Hepatol, 23, 351, 10.1111/j.1440-1746.2008.05314.x
Meyer, 2002, Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999, Ann Intern Med, 136, 13, 10.7326/0003-4819-136-1-200201010-00008
Perz, 2006, The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide, J Hepatol, 45, 529, 10.1016/j.jhep.2006.05.013
Bosch, 2004, Primary liver cancer: worldwide incidence and trends, Gastroenterol, 127, s5, 10.1053/j.gastro.2004.09.011
Raza, 2007, Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review, Br J Cancer, 96, 1127, 10.1038/sj.bjc.6603649
Seeff, 2006, Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity, Oncogene, 25, 3771, 10.1038/sj.onc.1209560
Chuang, 2009, Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection, Cancer Lett, 286, 9, 10.1016/j.canlet.2008.10.040
McQuillan, 1999, Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994, Am J Public Health, 89, 14, 10.2105/AJPH.89.1.14
Blakely, 1999, Hepatitis B carriage explains the excess rate of hepatocellular carcinoma for Maori, Pacific Island and Asian people compared to Europeans in New Zealand, Int J Epidemiol, 28, 204, 10.1093/ije/28.2.204
Kao, 2005, Changing disease burden of hepatocellular carcinoma in the Far East and Southeast Asia, Liver Int, 25, 696, 10.1111/j.1478-3231.2005.01139.x
Percy, 1990, The accuracy of liver cancer as the underlying cause of death on death certificates, Public Health Rep, 105, 361
Bosetti, 2008, Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004, Hepatology, 48, 137, 10.1002/hep.22312
La Vecchia, 2009, Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975, Ann Oncol, 21, 1323, 10.1093/annonc/mdp530
McGlynn, 2001, International trends and patterns of primary liver cancer, Int J Cancer, 94, 290, 10.1002/ijc.1456
Parkin, 2006, International patterns of cancer incidence and mortality, Cancer epidemiology and prevention, 101, 10.1093/acprof:oso/9780195149616.003.0008
Chang, 2009, Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study, J Natl Cancer Inst, 101, 1348, 10.1093/jnci/djp288
Chang, 1997, Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children, N Engl J Med, 336, 1855, 10.1056/NEJM199706263362602
Shariff, 2009, Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics, Expert Rev Gastroenterol Hepatol, 3, 353, 10.1586/egh.09.35
Frank, 2000, The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt, Lancet, 355, 887, 10.1016/S0140-6736(99)06527-7
Yoshizawa, 2002, Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future, Oncology, 62, 8, 10.1159/000048270
Taylor-Robinson, 1997, Increase in primary liver cancer in the UK, 1979-94, Lancet, 350, 1142, 10.1016/S0140-6736(05)63789-0
Wasley, 2000, Epidemiology of hepatitis C: geographic differences and temporal trends, Semin Liver Dis, 20, 1, 10.1055/s-2000-9506
Altekruse, 2009, Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005, J Clin Oncol, 27, 1485, 10.1200/JCO.2008.20.7753
El-Serag, 1999, Rising incidence of hepatocellular carcinoma in the United States, N Engl J Med, 340, 745, 10.1056/NEJM199903113401001
El-Serag, 2007, Epidemiology of hepatocellular carcinoma in USA, Hepatol Res, 37 Suppl 2, S88, 10.1111/j.1872-034X.2007.00168.x
El-Serag, 2000, Risk factors for the rising rates of primary liver cancer in the United States, Arch Intern Med, 160, 3227, 10.1001/archinte.160.21.3227
Calle, 2003, Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults, N Engl J Med, 348, 1625, 10.1056/NEJMoa021423
World Health Organization, 2004, Weekly epidemiologic record, Hepatitis B Vaccines, 79, 253
World Health Organization. Vaccine-preventable diseases: monitoring system 2009 global summary. WHO/UNICEF coverage estimates for 1980-2008, as of August 2009; [cited 1/5/2010]. Available from: http://www.who.int/immunization_monitoring/routine/immunization_coverage/en/index4.html.
Fritz, 2000, International classification of diseases for oncology
Bosetti, 2008, Trends in oesophageal cancer incidence and mortality in Europe, Int J Cancer, 122, 1118, 10.1002/ijc.23232
Hongo, 2009, Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity, J Gastroenterol Hepatol, 24, 729, 10.1111/j.1440-1746.2009.05824.x
Corley, 2001, Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database, Int J Epidemiol, 30, 1415, 10.1093/ije/30.6.1415
Gholipour, 2008, A histopathological study of esophageal cancer on the western side of the Caspian littoral from 1994 to 2003, Dis Esophagus, 21, 322, 10.1111/j.1442-2050.2007.00776.x
Islami, 2004, Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran, Br J Cancer, 90, 1402, 10.1038/sj.bjc.6601737
Tran, 2005, Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China, Int J Cancer, 113, 456, 10.1002/ijc.20616
Engel, 2003, Population attributable risks of esophageal and gastric cancers, J Natl Cancer Inst, 95, 1404, 10.1093/jnci/djg047
Kamangar, 2009, Environmental causes of esophageal cancer, Gastroenterol Clin North Am, 38, 27, 10.1016/j.gtc.2009.01.004
Nasrollahzadeh, 2008, Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran, Br J Cancer, 98, 1857, 10.1038/sj.bjc.6604369
Pourshams, 2005, Golestan cohort study of oesophageal cancer: feasibility and first results, Br J Cancer, 92, 176, 10.1038/sj.bjc.6602249
Hakami, 2008, Dietary intake of benzo(a)pyrene and risk of esophageal cancer in north of Iran, Nutr Cancer, 60, 216, 10.1080/01635580701684831
Islami, 2009, High-temperature beverages and foods and esophageal cancer risk—a systematic review, Int J Cancer, 125, 491, 10.1002/ijc.24445
Islami, 2009, Oesophageal cancer in Golestan Province, a high-incidence area in northern Iran—a review, Eur J Cancer, 45, 3156, 10.1016/j.ejca.2009.09.018
Fan, 2008, Alcohol, tobacco, and diet in relation to esophageal cancer: the Shanghai Cohort Study, Nutr Cancer, 60, 354, 10.1080/01635580701883011
Cook, 2009, Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005, Br J Cancer, 101, 855, 10.1038/sj.bjc.6605246
Lu, 2010, Increasing trend of the incidence of esophageal squamous cell carcinoma, but not adenocarcinoma, in Taiwan, Cancer Causes Control, 21, 269, 10.1007/s10552-009-9458-0
Lepage, 2008, Continuing rapid increase in esophageal adenocarcinoma in England and Wales, Am J Gastroenterol, 103, 2694, 10.1111/j.1572-0241.2008.02191.x
Post, 2007, Rising incidence of clinically evident Barrett's oesophagus in the Netherlands: a nation-wide registry of pathology reports, Scand J Gastroenterol, 42, 17, 10.1080/00365520600815654
Islami, 2008, Helicobacter pylori and esophageal cancer risk: a meta-analysis, Cancer Prev Res, 1, 329, 10.1158/1940-6207.CAPR-08-0109
Rokkas, 2007, Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis, Clin Gastroenterol Hepatol, 5, 1413, 10.1016/j.cgh.2007.08.010
Yeh, 2009, Effects of Helicobacter pylori infection and smoking on gastric cancer incidence in China: a population-level analysis of trends and projections, Cancer Causes Control, 20, 2021, 10.1007/s10552-009-9397-9
Vizcaino, 2002, Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995, Int J Cancer, 99, 860, 10.1002/ijc.10427
Yang, 2004, Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost, Int J Cancer, 109, 418, 10.1002/ijc.11719
Castellsague, 2006, Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention, J Natl Cancer Inst, 5, 303, 10.1093/jnci/djj067
International Collaboration of Epidemiological Studies of Cervical Cancer, 2009, Cervical carcinoma and sexual behavior: collaborative reanalysis of individual data on 15,461 women with cervical carcinoma and 29,164 women without cervical carcinoma from 21 epidemiological studies, Cancer Epidemiol Biomarkers Prev, 18, 1060, 10.1158/1055-9965.EPI-08-1186
Schiffman, 2006, Cervical cancer, Cancer epidemiology and prevention, 3rd ed., 1044, 10.1093/acprof:oso/9780195149616.003.0054
Maucort-Boulch, 2008, International correlation between human papillomavirus prevalence and cervical cancer incidence, Cancer Epidemiol Biomarkers Prev, 17, 717, 10.1158/1055-9965.EPI-07-2691
Bray, 2005, Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening, Cancer Epidemiol Biomarkers Prev, 14, 677, 10.1158/1055-9965.EPI-04-0569
Parkin, 2008, Burden and trends of type-specific human papillomavirus infections and related diseases in the Latin America and Caribbean region, Vaccine, 26 Suppl 11, L1, 10.1016/j.vaccine.2008.05.043
Mathew, 2009, Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix—worldwide, Asian Pac J Cancer Prev, 10, 645
Vizcaino, 2000, International trends in incidence of cervical cancer: II. Squamous-cell carcinoma, Int J Cancer, 86, 429, 10.1002/(SICI)1097-0215(20000501)86:3<429::AID-IJC20>3.0.CO;2-D
Chung, 2006, Cervical cancer incidence and survival in Korea: 1993-2002, Int J Gynecol Cancer, 16, 1833, 10.1111/j.1525-1438.2006.00708.x
Yang, 2004, Estimation and projection of the national profile of cancer mortality in China: 1991-2005, Br J Cancer, 90, 2157, 10.1038/sj.bjc.6601813
Chen, 2009, Effectiveness of national cervical cancer screening programme in Taiwan: 12-year experiences, Br J Cancer, 101, 174, 10.1038/sj.bjc.6605139
Anttila, 1999, Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence, Int J Cancer, 83, 59, 10.1002/(SICI)1097-0215(19990924)83:1<59::AID-IJC12>3.0.CO;2-N
Gustafsson, 1997, International incidence rates of invasive cervical cancer before cytological screening, Int J Cancer, 71, 159, 10.1002/(SICI)1097-0215(19970410)71:2<159::AID-IJC6>3.0.CO;2-#
Sherris, 2009, Evidence-based, alternative cervical cancer screening approaches in low-resource settings, Int Perspect Sex Reprod Health, 35, 147, 10.1363/3514709
Arbyn, 2008, Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India, Int J Cancer, 123, 153, 10.1002/ijc.23489
Sankaranarayanan, 2009, HPV screening for cervical cancer in rural India, N Engl J Med, 360, 1385, 10.1056/NEJMoa0808516
Sankaranarayanan, 2009, HPV vaccination: the promise & problems, Indian J Med Res, 130, 322
Yadav, 2008, Changing patterns of diet, physical activity and obesity among urban, rural and slum populations in north India, Obes Rev, 9, 400, 10.1111/j.1467-789X.2008.00505.x
Ziraba, 2009, Overweight and obesity in urban Africa: a problem of the rich or the poor?, BMC Public Health, 9, 465, 10.1186/1471-2458-9-465
World Health Organization, 2002, National cancer control programmes: policies and managerial guidelines, 2nd ed.
World Health Organization. The 58th World Health Assembly adopts resolution on cancer prevention and control. 2005 [cited 2010 April 1]. Available from: http://www.who.int/mediacentre/news/releases/2005/pr_wha05/en/index.html.
World Health Organization, 2009, 2008-2013 action plan for the global strategy for the prevention and control of noncommunicable diseases: prevent and control cardiovascular diseases, cancers, chronic respiratory diseases and diabetes
Ngoma, 2006, World Health Organization cancer priorities in developing countries, Ann Oncol, 17, viii9, 10.1093/annonc/mdl982